Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograft transplantation and the effect on early graft function

A. Davenport,M. Hopton,C. Bolton

DOI: https://doi.org/10.1111/j.1399-0012.1995.tb00318.x

1995-06-01

Clinical Transplantation

Abstract:We prospectively measured malondialdehyde (MDA), a marker of free radical oxygen damage during 44 renal transplant operations. When corrected for intra‐operative changes in plasma volume, there was a significant increase in the ratio of MDA to total cholesterol ( × 10 3), from a median of 0.32 (0.24‐0.44) (interquartile range) to 0.39 (0.31‐0.50) at 30 minutes following reperfusion, p<0.01 and to 0.36 (0.31‐0.51) after 60 minutes, p 250 umol/l at the end of the 1st post‐operative week), mean 0.32 (sem 0.08) at 30 min and 0.32 (0.09) at 60 min, compared to those with good function (serum creatinine <250 umol/l), 0.12 (0.05) and 0.10 (0.04) respectively, p<0.05. This suggests that the products of oxygen free radical damage can be measured during renal transplantation, and that they may have an adverse effect on early graft function.

surgery,transplantation